Abstract
BACKGROUND
The outcome after hospitalization for an exacerbation of chronic obstructive pulmonary disease (COPD) is unfavorable and uncertainty exists about factors predicting short and long-term prognosis.
OBJECTIVE
To identify clinical predictors of length of hospital stay (LOS) and three-year mortality after COPD exacerbations requiring hospitalization.
DESIGN
Retrospective analysis of prospectively collected data.
PARTICIPANTS AND METHODS
All consecutive patients hospitalized with COPD exacerbation were enrolled. Disease severity was estimated by FEV1, body mass index (BMI), Medical Research Council (MRC) chronic dyspnoea scale, previous hospitalizations, need for long-term oxygen treatment (LTOT), arterial oxygen and carbon dioxide partial pressures (PaO2 and PaCO2), pH and respiratory rate. Outcome was assessed by LOS and three-year mortality.
MAIN RESULTS
Out of 81 patients enrolled, three-year mortality data were available for 61. LOS was related to BMI, MRC scale and respiratory rate. Three-year mortality was related to FEV1, BMI, MRC scale, LTOT, and PaCO2. Multiple logistic regression analysis demonstrated that MRC scale was the only independent determinant of LOS, [p = 0.001, odds ratio (OR) 7.67 (95% CI 2.50–23.41)], whereas MRC scale and BMI predicted three-year mortality, [p = 0.001, OR 8.28 (95% CI 2.25–30.47) and p = 0.006, OR 6.91 (95% CI 1.74–27.48), respectively]. Cox regression analysis demonstrated identical results. Using receiver-operator-optimized thresholds for these variables (MRC > 2 and BMI < 25 kg/m2), we propose a prediction model that accurately determines three-year mortality risk.
CONCLUSIONS
In this study, MRC scale and BMI predicted outcome after COPD hospitalization. Pending further validation, this predictive model may contribute to identify patients with poor outcome even when spirometric data are unavailable.
Similar content being viewed by others
References
Global strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Lung Disease (GOLD) report updated November 2008. Available at: http://www.goldcopd.com/. Accessed 11th June 2009.
Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;29:1224–38.
Connors AFJ, Dawson NV, Thomas C, Harrell FE, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus W. Outcomes following acute exacerbation of severe chronic obstructive airways disease. Am J Respir Crit Care Med. 1996;154:959–67.
Groenewegen K, Schols A, Wouters E. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459–67.
Mushlin AI, Black ER, Connolly CA, Buonaccorso KM, Eberly SW. The necessary length of hospital stay for chronic pulmonary disease. JAMA. 1991;266(1):80–3.
Villalta J, Sequeira E, Cereijo AC, Sisó A, de la Sierra A. Factors predicting a short length of stay for acute exacerbations of chronic obstructive pulmonary disease. Med Clin (Barc). 2005;124(17):648–50.
Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, Sahin I, Kizkin O. Factors affecting survival of hospitalised patients with COPD. Eur Respir J. 2005;26(2):234–41.
Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–31.
Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005;34(5):491–6.
Menzies R, Gibbons W, Goldberg P. Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. Chest. 1995;398–405.
Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J. 2003;21(Suppl 41):46s–53s.
Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5- year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–40.
Calverley P, Anderson J, Celli B, Ferguson GT, Jenkins Ch, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–89.
Tsimogianni AM, Papiris SA, Kanavaki S, Stathopoulos GT, Sotiropoulou C, Manali ED, Michalopoulou P, Roussos C, Kotanidou A. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease. Respirology, in press
American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152:1107–36.
Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21:347–60.
Celli B, Cote C, Mario J, Casanova C, Montes de Oca M, Mendez RA, Plata VP, Cabral HJ. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004;350:1005–12.
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–6.
Kim S, Clark S, Camargo CA Jr. Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease. COPD. 2006;3(2):75–81.
Budweiser S, Jörres RA, Riedl T, Heinemann F, Hitzl AP, Windisch W, Pfeifer M. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest. 2007;131(6):1650–8.
Ai-Ping C, Lee KH, Lim TK. In-hospital mortality and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD. A retrospective study. Chest. 2005;128:518–24.
Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbation of chronic bronchitits. Chest. 2000;118(6):1557–65.
Van der Valk P, Monninkhof E, Van der Palen J, Zielhuis G, van Herwaarden C, Hendrix R. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis. 2004;39(7):980–6.
Panagiotakos DB, Pitsavos C, Chrysohoou C, Risvas G, Kontogianni MD, Zampelas A, Stefanadis C. Epidemiology of overweight and obesity in Greek adult population: the ATTICA Study. Obes Res. 2004;12(12):1914–20.
Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999;116:1632–7.
Donaldson GC, Seemungal TAR, Blowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–52.
Almagro P, Calbo E, Ochoea de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J. Mortality after hospitalisation for COPD. Chest. 2002;121:1441–8.
Garcia-Aymeric J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors for readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58:100–5.
Pitta F, Troosters Th, Probst V, Spruit MA, Decramer M, Gosselink R. Physical activity and Hospitalization for Exacerbation of COPD. Chest. 2006;129:536–44.
Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28:1245–57.
Acknowledgements
The authors wish to thank the following Chest Physicians for helping with the evaluation of patients: Dr. Spyros Tzannes, Dr. Alexandra Klitsa, Dr. Ioanna Kostara, Dr. Dimitra Haimala, and the Nursing Staff of Emergency and Pulmonary Department of “Sotiria", Chest Diseases Hospital. The statistician Christina Sotiropoulou had a major contribution in the statistical analysis and revision of the paper.
This work was supported by the Thorax Foundation, Athens, Greece.
Conflict of Interest
None disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsimogianni, A.M., Papiris, S.A., Stathopoulos, G.T. et al. Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease. J GEN INTERN MED 24, 1043–1048 (2009). https://doi.org/10.1007/s11606-009-1061-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-009-1061-2